You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Perioperative hypertension management
|
---|---|
Published in |
Vascular Health and Risk Management, June 2008
|
DOI | 10.2147/vhrm.s2471 |
Pubmed ID | |
Authors |
Joseph Varon, Paul E Marik |
Abstract |
Perioperative hypertension is commonly encountered in patients that undergo surgery. While attempts have been made to standardize the method to characterize the intraoperative hemodynamics, these methods still vary widely. In addition, there is a lack of consensus concerning treatment thresholds and appropriate therapeutic targets, making absolute recommendations about treatment difficult. Nevertheless, perioperative hypertension requires careful management. When treatment is necessary, therapy should be individualized for the patient. This paper reviews the pharmacologic agents and strategies commonly used in the management of perioperative hypertension. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Congo | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 287 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
Hungary | 1 | <1% |
Turkey | 1 | <1% |
Malaysia | 1 | <1% |
India | 1 | <1% |
Colombia | 1 | <1% |
Egypt | 1 | <1% |
Canada | 1 | <1% |
Spain | 1 | <1% |
Other | 1 | <1% |
Unknown | 275 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 76 | 26% |
Student > Master | 28 | 10% |
Researcher | 27 | 9% |
Other | 22 | 8% |
Student > Postgraduate | 22 | 8% |
Other | 69 | 24% |
Unknown | 43 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 175 | 61% |
Nursing and Health Professions | 16 | 6% |
Unspecified | 8 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
Agricultural and Biological Sciences | 6 | 2% |
Other | 28 | 10% |
Unknown | 46 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2018.
All research outputs
#7,357,897
of 25,377,790 outputs
Outputs from Vascular Health and Risk Management
#243
of 804 outputs
Outputs of similar age
#30,167
of 97,662 outputs
Outputs of similar age from Vascular Health and Risk Management
#10
of 16 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 804 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,662 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.